Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer (VERU-024)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05065411 |
|
Recruitment Status :
Terminated
(Business decision)
First Posted : October 4, 2021
Last Update Posted : February 26, 2024
|
Sponsor:
Veru Inc.
Information provided by (Responsible Party):
Veru Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | October 19, 2023 |
| Actual Study Completion Date : | January 9, 2024 |